Creatinine rise after fibrate therapy in renal graft recipients
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Drug-induced elevations in serum creatinine have been reported in those with mild to moderate renal failure and renal transplant recipients.
“Drug-induced elevations in serum creatinine have been reported in those with mild to moderate renal failure (46) and renal transplant recipients (47,48)”
From Effects of Fibrates in Kidney Disease (2012) · cites this paper as [48]
Cited by
Sorted by citations
Safety considerations with fibrate therapy
Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408 · see citing works
Safety issues and prospects for future generations of PPAR modulators
RUBENSTRUNK, A., HANF, R., HUM, D., FRUCHART, J., & STAELS, B. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.003 · Cited by 309 · see citing works
Lindenmayer, J. M., Schoenfeld, S., O'Grady, R., & Carney, J. K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.895 · Cited by 298 · see citing works
Effects of Fibrates in Kidney Disease
Jun, M., Zhu, B., Tonelli, M., Jardine, M. J., Patel, A., Neal, B., Liyanage, T., Keech, A., Cass, A., & Perkovic, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.049 · Cited by 189 · see citing works
Fibrate‐induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
Broeders, N., Knoop, C., Antoine, M., Tielemans, C., & Abramowicz, D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.1993 · Cited by 163 · see citing works
Fibrate therapy and renal function
Sica, D. A. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0051-5 · Cited by 33 · see citing works
- Authors
- Devuyst, O., Goffin, E., Pirson, Y., & Van Ypersele De Strihou, C.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1993-03
- Volume
- 341
- Issue
- 8848
- Pages
- 840
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2129554428
- Cited by
- 33
- References
- 0
- Citations by year
- 2025: 1 · 2023: 1 · 2020: 1 · 2014: 1 · 2013: 1 · 2012: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- fibrate therapy, kidney transplant recipients, drug-induced nephrotoxicity, kidney transplantation, lipid-lowering drugs
- MeSH terms
- Hypolipidemic Agents, Bezafibrate, Clofibric Acid, Creatinine, Female, Humans, Hypercholesterolemia, Male, Fenofibrate, Kidney Transplantation, Fibric Acids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
